PPARα Activation Overcomes Fibroinflammatory Anti-PD-1 Resistance in Liver Cancer via GSDME Pyroptosis
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Cancer researchers have designed a synthetic peptide that turns tumour cells into highly visible targets for the immune system by ...
Pancreatic cancer may be one of the most difficult cancers to treat, but new research points to a microscopic event ...
The DNA damage response (DDR) and the immune system may look like separate defense networks, but new research underscores how ...
KAIST researchers have reported a new class of T-cell-receptor-like antibodies designed to recognize an intracellular cancer mutation with high specificity. ...
Pancreatic cancer is notoriously resistant to immunotherapy because many tumors develop an immune-suppressive, oxygen-poor “cold” microenvironment that blocks effective T ...
A new open-access Review in Ferroptosis and Oxidative Stress spotlights Z-nucleic acid-binding protein 1 (ZBP1), framing it as an emerging ...
In a groundbreaking study that could have significant implications for cancer treatment, researchers have uncovered a surprising link between polyvinyl ...
Scientists at Trinity College Dublin and University College Dublin have uncovered a groundbreaking dietary approach to enhance the immune system’s ...
A team of researchers at The University of Texas MD Anderson Cancer Center has developed an innovative microfluidic platform named ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine